Corcept Therapeutics, Inc. (CORT)

52.15 +0.82 (+1.60%) USD  |  NASDAQ  |  May 06, 16:00
52.56 +0.41 (+0.79%) After-Hours: 07:03
More

Corcept Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Integer Holdings Corp. Upgrade
Stryker Corp. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade